Table 1.
Baseline characteristics of lung cancer patients
| Total n = 112 (100%) | Reference n = 27 (24%) | VA n = 29 (26%) | Rad n = 32 (29%) | RadVA n = 24 (21%) | |
|---|---|---|---|---|---|
| Sex | |||||
| Men, n (%) | 50 (45) | 15 (56) | 6 (21) | 17 (53) | 12 (50) |
| Women, n (%) | 62 (55) | 12 (44) | 23 (79) | 15 (47) | 12 (50) |
| p = 0.016* | p = 1 | p = 0.908 | |||
| Age, years | |||||
| Median (IQR) | 70 (63–75) | 71 (64–76) | 65 (58–74) | 72 (67–76) | 68 (62–75) |
| p = 0.119 | p = 0.659 | p = 0.363 | |||
| Histology | |||||
| Non-small cell LC (NSCLC) | 103 (92) | 25 (93) | 29 (100) | 31 (97) | 18 (75) |
| Small cell LC (SCLC) | 6 (5) | 0 | 0 | 1 (3) | 5 (21) |
| Other# | 3 (3) | 2 (7) | 0 | 0 | 1 (4) |
| p = 0.328 | p = 0.198 | p = 0.042* | |||
| UICC tumor stage | |||||
| I | 23 (21) | 11 (41) | 2 (7) | 10 (31) | 0 |
| II | 13 (12) | 6 (22) | 2 (7) | 5 (16) | 0 |
| III | 30 (27) | 6 (22) | 6 (21) | 10 (31) | 8 (33) |
| IV | 46 (41) | 4 (15) | 19 (66) | 7 (22) | 6 (67) |
| p = 0.0004* | p = 0.672 | p = 0.0018* | |||
UICC Union for International Cancer Care; IQR Interquartile Range
Significant p-values are indicated: *p-value < 0.05
#Other: one spindle cell carcinoid, two carcinoids without further specification